MedPath

Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

Not Applicable
Completed
Conditions
Covid-19
Registration Number
NCT06259656
Lead Sponsor
Vachira Phuket Hospital
Brief Summary

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.

Detailed Description

The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • Thai term pregnant women
  • 18-45 year old
  • At least 1 covid vaccination received
  • admission at Vachira Phuket Hospital Labor Room
Exclusion Criteria
  • Do not want to participate
  • Unstable or Emergency condition

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) Level1 month

Test for correlation of level in maternal and cord blood

Secondary Outcome Measures
NameTimeMethod
Analysed time effect from last vaccination and type.1 month

Test for time effect after last dose of vaccination

Trial Locations

Locations (1)

Vachira Phuket Hospital

🇹🇭

Phuket, Thailand

Vachira Phuket Hospital
🇹🇭Phuket, Thailand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.